Who Paid My Doc
Andrew Watt
Plastic and Reconstructive Surgery Stanford, CA Medical Doctor
NPI 1356538334 CMS profile 107361
300 Pasteur Dr, Stanford, CA 94305
General payments
$54,693
Research payments
$0
Ownership & investment interest
$0
Through program year 2025, Andrew Watt of Stanford, CA is reported in the CMS Open Payments database as having received $54,693 across 129 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 95th percentile of Plastic and Reconstructive Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
7 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $11,871 | 23 | |
| 2024 | General | $4,360 | 14 | |
| 2023 | General | $15,427 | 20 | |
| 2022 | General | $9,053 | 17 | |
| 2021 | General | $4,518 | 16 | |
| 2020 | General | $1,215 | 13 | |
| 2019 | General | $8,249 | 26 |
Beside peers
- Andrew Watt
- Plastic and Reconstructive Surgery median
- Middle half of Plastic and Reconstructive Surgery
- National median
In program year 2025, general payments to Andrew Watt were reported at $11,871. Among 2,070 Plastic and Reconstructive Surgery profiles paid that year, the median was $442 and the middle half received between $150 and $1,242.
Show as a table
| Year | Andrew Watt | Plastic and Reconstructive Surgery median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $8,249 | $335 | $121–$1,264 | $163 |
| 2020 | $1,215 | $162 | $57–$417 | $114 |
| 2021 | $4,518 | $245 | $89–$735 | $132 |
| 2022 | $9,053 | $325 | $120–$932 | $149 |
| 2023 | $15,427 | $343 | $129–$999 | $160 |
| 2024 | $4,360 | $390 | $141–$1,085 | $164 |
| 2025 | $11,871 | $442 | $150–$1,242 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Billing to Medicare
Part B · data year 2024 · 64 billing codesPaid by Medicare
$61,339
Medicare patients
92
Services billed
404
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 58% | |
| Arthritis | 53% | |
| Depression | 24% | |
| Ischemic heart disease | 23% | |
| Atrial fibrillation | 20% | |
| Cancer | 20% | |
| Diabetes | 18% | |
| Osteoporosis | 18% |
| Drug given in the clinic | Where | Patients | Services | Paid by Medicare |
|---|---|---|---|---|
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 | Office | 23 | 76 | $59 |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
129 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Plastic and Reconstructive Surgery in California
Mark Suski
Plastic and Reconstructive Surgery · Thousand Oaks, CA
Corey Maas
Plastic and Reconstructive Surgery · San Francisco, CA
Arian Mowlavi
Plastic and Reconstructive Surgery · Laguna Beach, CA
Charles Lee
Plastic and Reconstructive Surgery · San Francisco, CA
David Sieber
Plastic and Reconstructive Surgery · San Francisco, CA
David Kulber
Plastic and Reconstructive Surgery · Los Angeles, CA
Related records
Plastic and Reconstructive Surgery in California
Practitioners in the same specialty and state, ranked by reported value.
All Plastic and Reconstructive Surgery
Everyone recorded under this specialty, nationwide.
Doctors in California
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.